Director Yehuda Eliya term expires, leaves Raphael board effective Dec 31, 2025

Raphael Pharmaceutical Inc.

Dr. Yehuda Eliya's board term expired Dec 31, 2025; ceased serving as director.
Departure not related to any disagreement with company operations, policies, or practices.
No replacement director announced as of filing date March 24, 2026.

item 5.02

Raphael Pharmaceutical Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-033507

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.